These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1768486)

  • 1. Cost and reimbursement rates for investigational circulatory support.
    Swartz MT; Reedy JE; Lohmann D; Bennett T; McBride LR; Pennington DG
    ASAIO Trans; 1991; 37(4):549-52. PubMed ID: 1768486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of patients receiving advanced mechanical circulatory support.
    McBride LR; Lowdermilk GA; Fiore AC; Moroney DA; Brannan JA; Swartz MT
    J Thorac Cardiovasc Surg; 2000 May; 119(5):1015-20. PubMed ID: 10788824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for successful reimbursement for investigational circulatory support.
    Shinn JA
    Prog Cardiovasc Nurs; 1997; 12(3):42-3. PubMed ID: 9287368
    [No Abstract]   [Full Text] [Related]  

  • 4. Noncardiac operations in patients supported with mechanical circulatory support devices.
    Votapka TV; Pennington DG; McBride LR; Kaminski DL; Andrus CH; Swartz MT
    J Am Coll Surg; 1994 Sep; 179(3):318-20. PubMed ID: 8069428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of hospitalization in Crohn's disease.
    Cohen RD; Larson LR; Roth JM; Becker RV; Mummert LL
    Am J Gastroenterol; 2000 Feb; 95(2):524-30. PubMed ID: 10685762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost analysis of the Novacor Left Ventricular Assist System as an outpatient bridge to heart transplantation.
    Arabia FA; Smith RG; Jaffe C; Wild JC; Rose DS; Nelson RJ; McClellan DM; Acuna GA; Edling NG; Harrington NK; Rabago G; Tsen AC; Arzouman DA; Sethi GK; Copeland JG
    ASAIO J; 1996; 42(5):M546-9. PubMed ID: 8944939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and reimbursement gaps after implementation of third-generation left ventricular assist devices.
    Mishra V; Geiran O; Fiane AE; Sørensen G; Andresen S; Olsen EK; Khushi I; Hagen TP
    J Heart Lung Transplant; 2010 Jan; 29(1):72-8. PubMed ID: 19783175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement.
    Messori A; Trippoli S; Bonacchi M; Sani G
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):480-5. PubMed ID: 19619799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist device programs: design and function.
    Van Meter CH; Hollenbach Ordoyne SK; Kateiva JE
    Ann Thorac Surg; 1999 Aug; 68(2):643-5. PubMed ID: 10475463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why is There Discordance between the Reimbursement of High-Cost 'Life-Extending' Pharmaceuticals and Medical Devices? The Funding of Ventricular Assist Devices in Australia.
    Saing S; van der Linden N; Hayward C; Goodall S
    Appl Health Econ Health Policy; 2019 Aug; 17(4):421-431. PubMed ID: 30906972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart transplant and left ventricular assist device costs.
    Digiorgi PL; Reel MS; Thornton B; Burton E; Naka Y; Oz MC
    J Heart Lung Transplant; 2005 Feb; 24(2):200-4. PubMed ID: 15701438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicare reimbursement for destination therapy: the right decision at the right time?
    Mussivand T
    Artif Organs; 2004 Jun; 28(6):523-5. PubMed ID: 15153142
    [No Abstract]   [Full Text] [Related]  

  • 14. Hospitalization charges, costs, and income for firearm-related injuries at a university trauma center.
    Kizer KW; Vassar MJ; Harry RL; Layton KD
    JAMA; 1995 Jun; 273(22):1768-73. PubMed ID: 7769771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with the Novacor ventricular assist system. Bridge to transplantation and the transition to permanent application.
    McCarthy PM; Portner PM; Tobler HG; Starnes VA; Ramasamy N; Oyer PE
    J Thorac Cardiovasc Surg; 1991 Oct; 102(4):578-86; discussion 586-7. PubMed ID: 1921434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist devices as permanent heart failure therapy: the price of progress.
    Oz MC; Gelijns AC; Miller L; Wang C; Nickens P; Arons R; Aaronson K; Richenbacher W; van Meter C; Nelson K; Weinberg A; Watson J; Rose EA; Moskowitz AJ
    Ann Surg; 2003 Oct; 238(4):577-83; discussion 583-5. PubMed ID: 14530729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
    Farrar DJ
    J Heart Lung Transplant; 1994; 13(1 Pt 1):93-100; discussion 100-1. PubMed ID: 8167132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State of the art. Circulatory support.
    Kantrowitz A
    ASAIO Trans; 1988; 34(3):445-9. PubMed ID: 3058180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Summary of the clinical use of the Symbion total artificial heart: a registry report.
    Johnson KE; Prieto M; Joyce LD; Pritzker M; Emery RW
    J Heart Lung Transplant; 1992; 11(1 Pt 1):103-16. PubMed ID: 1540598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs associated with ventricular assist device use in children.
    Mahle WT; Ianucci G; Vincent RN; Kanter KR
    Ann Thorac Surg; 2008 Nov; 86(5):1592-7. PubMed ID: 19049755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.